ArticleTheranostics2025

JARID1D-dependent androgen receptor and JunD signaling activation of osteoclast differentiation inhibits prostate cancer bone metastasis through demethylating H3K4.

Yaohua Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.